Literature DB >> 33420008

Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress.

Zhusheng Huang1, Yuxiang Wang1, Dan Yao1, Jinhui Wu1,2,3, Yiqiao Hu4,5,6, Ahu Yuan7,8,9.   

Abstract

Radiation therapy can potentially induce immunogenic cell class="Disease">death, thereby class="Chemical">priming anti-class="Chemical">pan class="Disease">tumor adaptive immune responses. However, radiation-induced systemic immune responses are very rare and insufficient to meet clinical needs. Here, we demonstrate a synergetic strategy for boosting radiation-induced immunogenic cell death by constructing gadolinium-hemin based nanoscale coordination polymers to simultaneously perform X-ray deposition and glutathione depletion. Subsequently, immunogenic cell death is induced by sensitized radiation to potentiate checkpoint blockade immunotherapies against primary and metastatic tumors. In conclusion, nanoscale coordination polymers-sensitized radiation therapy exhibits biocompatibility and therapeutic efficacy in preclinical cancer models, and has the potential for further application in cancer radio-immunotherapy.

Entities:  

Year:  2021        PMID: 33420008     DOI: 10.1038/s41467-020-20243-8

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  56 in total

Review 1.  A fresh look at tumor immunosurveillance and immunotherapy.

Authors:  M J Smyth; D I Godfrey; J A Trapani
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

Review 2.  The future of immune checkpoint therapy.

Authors:  Padmanee Sharma; James P Allison
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

Review 3.  Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy.

Authors:  Oliver Kepp; Lorenzo Galluzzi; Isabelle Martins; Frederic Schlemmer; Sandy Adjemian; Mickael Michaud; Abdul Qader Sukkurwala; Laurie Menger; Laurence Zitvogel; Guido Kroemer
Journal:  Cancer Metastasis Rev       Date:  2011-03       Impact factor: 9.264

Review 4.  Radiotherapy and immunogenic cell death.

Authors:  Encouse B Golden; Lionel Apetoh
Journal:  Semin Radiat Oncol       Date:  2015-01       Impact factor: 5.934

Review 5.  Immunogenic cell death in cancer and infectious disease.

Authors:  Lorenzo Galluzzi; Aitziber Buqué; Oliver Kepp; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Rev Immunol       Date:  2016-10-17       Impact factor: 53.106

Review 6.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

Review 7.  Oncolytic virotherapy and immunogenic cancer cell death: sharpening the sword for improved cancer treatment strategies.

Authors:  Samuel T Workenhe; Karen L Mossman
Journal:  Mol Ther       Date:  2013-10-19       Impact factor: 11.454

Review 8.  Immunogenic cell death in cancer therapy.

Authors:  Guido Kroemer; Lorenzo Galluzzi; Oliver Kepp; Laurence Zitvogel
Journal:  Annu Rev Immunol       Date:  2012-11-12       Impact factor: 28.527

Review 9.  Oncology meets immunology: the cancer-immunity cycle.

Authors:  Daniel S Chen; Ira Mellman
Journal:  Immunity       Date:  2013-07-25       Impact factor: 31.745

Review 10.  ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses.

Authors:  Abhishek D Garg; Patrizia Agostinis
Journal:  Photochem Photobiol Sci       Date:  2014-02-04       Impact factor: 3.982

View more
  10 in total

1.  Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling.

Authors:  Davide Ferrari; Stefania Gessi; Stefania Merighi; Manuela Nigro; Alessia Travagli; Jorge S Burns
Journal:  Front Cell Dev Biol       Date:  2022-05-04

2.  Stimuli-responsive nano vehicle enhances cancer immunotherapy by coordinating mitochondria-targeted immunogenic cell death and PD-L1 blockade.

Authors:  Qiuyi Li; Cheng Chen; Jinxia Kong; Lian Li; Junlin Li; Yuan Huang
Journal:  Acta Pharm Sin B       Date:  2021-12-29       Impact factor: 14.903

3.  FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer.

Authors:  Yun Huang; Hai-Liang Zhang; Zhi-Ling Li; Tian Du; Yu-Hong Chen; Yan Wang; Huan-He Ni; Kai-Ming Zhang; Jia Mai; Bing-Xin Hu; Jun-Hao Huang; Li-Huan Zhou; Dong Yang; Xiao-Dan Peng; Gong-Kan Feng; Jun Tang; Xiao-Feng Zhu; Rong Deng
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

Review 4.  Immunogenic Cell Death Induction by Ionizing Radiation.

Authors:  Mengqin Zhu; Mengdie Yang; Jiajia Zhang; Yuzhen Yin; Xin Fan; Yu Zhang; Shanshan Qin; Han Zhang; Fei Yu
Journal:  Front Immunol       Date:  2021-08-20       Impact factor: 7.561

5.  Biodegradable Nanoprobe for NIR-II Fluorescence Image-Guided Surgery and Enhanced Breast Cancer Radiotherapy Efficacy.

Authors:  Rui-Qin Yang; Pei-Yuan Wang; Kang-Liang Lou; Yong-Ying Dang; Hai-Na Tian; Yang Li; Yi-Yang Gao; Wen-He Huang; Yong-Qu Zhang; Xiao-Long Liu; Guo-Jun Zhang
Journal:  Adv Sci (Weinh)       Date:  2022-02-16       Impact factor: 17.521

6.  NIR-light-controlled G-quadruplex hydrogel for synergistically enhancing photodynamic therapy via sustained delivery of metformin and catalase-like activity in breast cancer.

Authors:  Yanting Sun; Kang Fang; Xiaochun Hu; Jingxian Yang; Zhengyang Jiang; Lei Feng; Ruihao Li; Yiming Rao; Shuo Shi; Chunyan Dong
Journal:  Mater Today Bio       Date:  2022-08-01

Review 7.  Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency.

Authors:  Zhilin Li; Xiaoqin Lai; Shiqin Fu; Long Ren; Hao Cai; Hu Zhang; Zhongwei Gu; Xuelei Ma; Kui Luo
Journal:  Adv Sci (Weinh)       Date:  2022-06-02       Impact factor: 17.521

Review 8.  Recent advances in nano-drug delivery systems for synergistic antitumor immunotherapy.

Authors:  Bonan Zhao; Xiang Li; Ying Kong; Wenbo Wang; Tingting Wen; Yanru Zhang; Zhiyong Deng; Yafang Chen; Xian Zheng
Journal:  Front Bioeng Biotechnol       Date:  2022-09-08

9.  MDSCs Aggravate the Asthmatic Progression in Children and OVA-Allergic Mice by Regulating the Th1/Th2/Th17 Responses.

Authors:  Long Lin; Shifu Xu; Feng Peng; Haili Jin; Fengchun Xiao
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-22       Impact factor: 2.650

Review 10.  Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice.

Authors:  Jinguo Zhang; Shuaikang Pan; Chen Jian; Li Hao; Jie Dong; Qingqing Sun; Hongwei Jin; Xinghua Han
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.